Poster Abstract Session:
154. HIV Drug Resistance
Friday, October 6, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Tracks: Adult ID, HIV-STD-TB


Presentations:
HIV Transmitted Drug Resistance in the Philippines: The Case for Baseline Genotyping and Drug Resistance Testing
Edsel Maurice Salvana, MD, DTM&H, FIDSA; Brian Schwem, PhD; Christine Penalosa, MD; Geraldine Arevalo, BS; Nina Dungca, MS; Jodor Lim, MD, FPCP, FPSMID; Katerina Leyritana, MD; Raul Destura, MD
Posters
  • Salvana TDR Poster 1368 v2.pdf (599.9 kB)
  • Transmitted Drug Resistance in Treatment-naïve HIV-Infected VCT clients in Taiwan, 2007-2016
    Hung-Chin Tsai, MD, PhD; I-Tzu Chen, MSc; Susan Shin-Jung Lee, MD, PhD; Yao-Shen Chen, MD, MSc
    Antiretroviral Therapy Prescribing Practices and Virologic Response in HIV-Infected Individuals with the M184V Mutation: Results from the 550 Clinic Cohort Study
    Lauren Kirkpatrick, PharmD; Paula Peyrani, MD; Anupama Raghuram, MD; Cathy Spencer, PharmD; Mary Bishop, RPH; Maura Wojak, PharmD; Ashley Ross, PharmD; Jennifer Wiedmar, PharmD; Daniel Truelove, PharmD
    Posters
  • LKirkpatrick_ ID Week.pdf (112.9 kB)
  • Moderate Levels of Pre-Treatment HIV Drug Resistance — Zimbabwe, April–July 2015
    Juliana Da Silva, MD; Janet Dzangare, BA; Elizabeth Gonese, BA; Mutsa Mhangara, MD; Owen Mugurungi, MD; Beth Barr, DrPH; Spencer Lloyd, MD; Elliot Raizes, MD
    Reviewing Clinical Outcomes of Patients with the E157Q Mutation in Detroit
    David Pavkovich, MD; Deborah Richmond, MSN, CNP; Jennifer Veltman, MD
    Clinical Outcomes Following the Use of Archived HIV-1 DNA Sequencing to Guide Antiretroviral Therapy Regimen Adjustment and Simplification
    Kristen Ellis, PharmD; George Nawas, PharmD; Connie Chan, PharmD; Lawrence York, PharmD; Alexander Mar, MPH; Tirdad Zangeneh, DO
    Posters
  • Archive ID Week Poster.pdf (435.6 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.